Trial Profile
Assessing the Efficacy of Reslizumab Treatment in Terms of Reduction in Oral Corticosteroids in Patients with Eosinophilic Granulomatosis with Polyangiitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Mar 2020
Price :
$35
*
At a glance
- Drugs Reslizumab (Primary) ; Corticosteroids; Prednisolone
- Indications Asthma; Churg-Strauss syndrome
- Focus Therapeutic Use
- 03 Mar 2020 New trial record